Viatris’ Dividend Has Room to Grow, but Will Management Deliver?

Viatris Inc. (NASDAQ:VTRS) is a familiar name in the pharmaceutical industry, with a portfolio that stretches from branded medications to generics and fresh, innovative therapies. Its broad reach and diverse lineup help bring in steady revenue year after year. Still, the company faces heavy competition, persistent price pressures, and the ongoing risk of losing exclusivity […]